Vertex Pharmaceuticals
The latest news about Vertex Pharmaceuticals: headlines, AI summaries and the full story from every source.
- Vertex Pharmaceuticals Expands Beyond Cystic Fibrosis at Cantor Conference
- Vertex Acquires Crinetics for $10 Billion; Viking Therapeutics Seen as Potential Next Target
- Vertex Pharmaceuticals Hits 52-Week High Amid Regulatory and Developmental Catalysts
- RBC Raises Price Target for Vertex Pharmaceuticals Amid Biotech Sector Outlook Update